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MEDIA RELEASE
October 29, 1986
UM BIOCHEMIST RECEIVES $226,000 IN RESEARCH
FUNDS FROM NATIONAL INSTITUTES OF HEALTH
MISSOULA —
University of Montana chemistry professor Walter Hill has
just received $226,000 to continue studying some of life's most
closely-held secrets.

The three-year grant comes from the

National Institutes of Health (NIH), a federal agency which,
along with the National Science Foundation (N S F ), has funneled
over 1.5 million dollars into Hill’s research during his career
at the University of Montana.
What is Hill studying that warrants such support?

His

research centers on ribosomes, the tiny, double-bodied homes to
strings of ribonucleic acid (RNA) and proteins.

The ribosomes

take genetic blueprints from the deoxyribose nucleic acid (DNA,
the substance of genes) and manufacture proteins for the body
according to their directions.

But how the ribosomes make that

transition from communicating to manufacturing is still a
mystery.

Unlocking that mystery holds implications for major

breakthroughs in diagnostic medicine, cancer research and
immunology.
Hill and his fellow scientists and researchers know the
secrets to the communication and manufacturing processes lie in
the way that ribosomes bond with various kinds of RNA.
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explains that some RNA contains all the genetic information cells
need to function.

DNA initially transfers this information to

RNA, which in turn takes it to the ribosome where the message is
decoded and protein is made.
It's something like using different languages and alphabets,
Hill says.

Messenger-RNA (the main communicator of the genetic

message), and DNA have only four letters in a particular
"biological alphabet" to use.

But the proteins, which are the

ultimate product, contain as many as 20 letters (amino acids) in
what is essentially a different biological language.

The

ribosome serves as the translation device.
But in human biology, of course, glitches in translation can
and do occur.

For example, Hill knows that the way bonding

occurs between the RNA and ribosomes in a person who is ill may
not be the same as the bonding in a healthy individual.

And he

knows that deliberate intervention in this bonding process has
already provided massive medical benefits to mankind in the form
of antibiotics, which work at the bonding sites themselves.
These bonding sites or

"nests," within the ribosomes serve

as bonding locations for various kinds of RNA.

Antibiotics

interfere in the nests, stopping the ribosomes from working, and
effectively canceling cell growth, slowing or halting the course
of an infection.

Because interfering with bonding can cancel

cell growth, Hill says the implications for finding a cure for
cancer are also strong.
more
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Hill and his research team know they can prevent protein
manufacture entirely in a laboratory simulation.

For example,

they can synthesize small pieces of DNA in their lab at the
university and cover a loop or ’’nest” site on one of the
ribosome's sub-units with these DNA strings.

The DNA cover

prevents the loop, which is looking for its answering site on the
other part of the ribosome, from finding its match and joining
with it.

Removing the DNA pieces leaves the loop clear once

again; the two halves of the ribosome bond through the loop and
the ribosome is again functional.
A different protein-RNA link recently made national
headlines when scientists at Children's Hospital in Boston and
Harvard Medical School reported the discovery of the gene
responsible for Duchenne muscular dystrophy, a progressive
disease that destroys muscle tissue.
The culprit gene serves as the blueprint for the manufacture
of a specific protein in muscle tissue.

When that protein is

missing or altered, Duchenne muscular dystrophy results.

The

scientists found that the gene produced messenger-RNA that would
direct the formation of the protein chain.

The garbled genetic

code inserted a faulty amino acid into the protein chain, causing
the protein to either not be created at all or to be altered.
Hill has been fascinated with ribosomes since his graduate
student days at the University of Wisconsin-Madison.

In addition

to the funding he has received from NIH and N S F , he has also
more
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received NIH pre-doctoral and post-doctoral fellowships as well
as an NIH Research Career Development Award.
Hill collaborates with scientists world-wide in the course
of his research.

In September he traveled to the Soviet Union at

the invitation of the Soviet Academy of Sciences to present his
work.

He also collaborates with scientists at the University of

Texas, Yale and UCLA as well as scientists in Moscow and Berlin.
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